People suffering with migraine headaches may now find quick relief - as fast as 15 minutes - with a simple-to-use nasal spray of the drug sumatriptan, an effective migraine treatment also prescribed in oral or injection form. EMBAROGED FOR RELEASE UNTIL NOVEMBER 21, 1997
Two recent studies show that the drug zolmitriptan (brand name Zomig) begins to relieve severe or moderate migraine headache in as little as 30 minutes. EMBARGOED FOR RELEASE UNTIL NOVEMBER 21, 1997
Shakespeare vividly described sleep disorders affecting his characters centuries before the public and medical professionals recognized these common, often treatable problems, according to a Los Angeles neurologist and sleep disorder specialist.
Headaches that begin during exercise and go away with rest may be a sign of heart disease, according to a report in the September issue of Neurology, the scientific journal of the American Academy of Neurology. Embargoed For Release Until Monday, September 22, 1997.
The American Academy of Neurology has issued guidelines for neurologists on the ethical considerations that arise in the managed care environment. The guidelines are published in the August issue of the AAN's scientfic journal, Neurology. EMBARGOED UNTIL AUGUST 20, 1997.
The drug pramipexole improves symptoms for advanced ParkinsonÃs disease patients, according to a study published in the July issue of the American Academy of NeurologyÃs scientific journal, Neurology.
AlzheimerÃs disease patients who take part in clinical trials are 50 percent less likely to be placed in a nursing home, according to a study published in the July issue of the American Academy of NeurologyÃs scientific journal, Neurology.
Women who use estrogen replacement therapy are less likely to develop Alzheimer's disease, according to a study published in the June issue of the American Academy of Neurology's scientific journal, Neurology.
Existing research shows no link between silicone breast implants and neurological disorders, according to a special article published by the American Academy of Neurology's Practice Committee in the June issue of the Academy's scientific journal, Neurology.
Medical professionals and patients are not being informed or warned about the serious dangers associated with a migraine drug, according to an article published in the May issue of the American Academy of Neurology's scientific journal, Neurology.
Researchers have discovered a new eating disorder in which some patients with right anterior brain lesions suddenly become compulsively addicted to thinking about and eating fine foods. Called Gourmand syndrome, the new disorder is presented in the May issue of the American Academy of Neurology's scientific journal, Neurology.
News Briefs from the American Academy of Neurology Meeting April 12-19: 1) Thrombolytic Therapy Brings Brain-Dead Patient Back to Life; 2) Sleep Disorder in Parkinson's Disease Patients Can Lead to Nocturnal Injury Please note individual embargo dates.
Studies to be Presented at the American Academy of Neurology Annual Meeting: 1) Gene Therapy in Monkeys May Lead to Treatment for Alzheimer's Disease 2) Stroke Patients Improve Walking Ability with New Therapy
News from AAN Annual Meeting April 12-19: 1) Drug Improves Productivity by 50 Percent for Migraine Sufferers. Embargoed until April 15, 1996; 2) For Immediate Release: AAN Participates in Second Annual Brain Awareness Week, March 17-23
Media representatives are invited to attend the AAN Annual Meeting April 12-19 in Boston. Following are some of the studies that will be presented: 1) Smoking Increases Risk of Dementia 2) Estrogen Replacement Therapy Tied to Reduced Risk of Alzheimer's Disease 3) Pallidotomy Improves Verbal Memory for Parkinson's Patients
Cladribine, a chemotherapy drug, drastically lowered counts of a kind of white blood cell (known as a lymphocyte) in patients with chronic progressive multiple sclerosis, according to a study presented during the American Academy of Neurology's 49th Annual Meeting April 12-19 in Boston. EMBARGOED FOR RELEASE UNTIL 7:30 AM, WEDNESDAY, APRIL 16, 1997
Individuals who sleep more than eight hours a night or take daytime naps are 50 percent more likely to suffer a stroke or develop heart disease, according to a study published in the April issue of the American Academy of Neurology's scientific journal, Neurology.
Media representatives are invited to attend the American Academy of Neurology's 49th Annual Meeting April 12-19 in Boston, MA. Studies presented at the meeting include: 1) Extensive Decongestant Use Linked to Stroke; 2) Gene Affects Risk of Alzheimer's Disease Differently Among Races Please note individual embargo dates.
Briefs from March Neurology: 1) Out of the Clear Blue Sky: Rugby Spectator Struck by Lightning 2) Treatment Shows Small Benefit for Some Inclusion-Body Myositis Patients
Neurology News Briefs: 1) Proper Management of Sports-Related Concussion Can Prevent Years of Chronic Headaches, Confusion and Memory Loss 2) Radiosurgery Proven Safe, Effective Treatment for Trigeminal Neuralgia
News Briefs from Neurology 1) New Treatment Developed for Parkinson's Disease 2) Study Shows New Treatment for Menstrual Migraine 3) Persian Gulf War Symptoms Not Related to Exposure to Toxins
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right